News | Artificial Intelligence | April 07, 2020

Nanox Partners With Qure.ai to Integrate AI-based Algorithms for Medical Imaging

The agreement is intended to integrate Qure.ai’s proprietary technology for chest x-ray screening and head CT triage in the Nanox.Cloud to improve imaging solutions and increase patient access to medical imaging world-wide

The agreement is intended to integrate Qure.ai’s proprietary technology for chest x-ray screening and head CT triage in the Nanox.Cloud to improve imaging solutions and increase patient access to medical imaging world-wide

April 7, 2020 — -NANO-X IMAGING LTD (Nanox), an innovative medical imaging company, announces its collaboration with Qure.ai, a leading healthcare AI startup, to integrate Qure.ai’s diagnostics solution into Nanox’s planned cloud-based software platform, the Nanox.CLOUD. This partnership follows another agreement with CureMetrix that was announced earlier this year.

Nanox is working to expand the range of medical imaging services it intends to provide to improve the accessibility and affordability of early-detection services. The Nanox.CLOUD is designed to provide an end-to-end medical imaging service, including services such as image repository, radiologist matching, online and offline diagnostics review and annotation, connectivity to diagnostic assistive artificial intelligence (AI) systems, billing and reporting.

A head computed tomography (CT) scan is usually a diagnostic test patients undergo at an early stage if they have a head injury or symptoms suggesting stroke. Radiologists in ICUs or ERs might not be immediately available to read a scan or might have many scans pending. Prompt detection of head injury is critical to increase patients’ chances for recovery.

Qure.ai’s solution detects critical abnormalities, such as bleeds, fractures, mass effect and midline shift, localizes them and quantifies their severity. Qure.ai’s solutions are all CE certified, and its head CT product (qER) is the only solution in the industry to detect every critical brain abnormality on a head CT, including five types of intracranial hemorrhages, cranial fractures, infarcts, midline shift and mass effect (for tumor detection).

"We’re gradually onboarding the key players in AI and healthcare that share our vision. Qure.ai is joining our planned imaging platform aimed to decrease diagnostic results turnaround time, increase diagnostic accuracy and help radiologists deal with the rising screening demands and workload,” said Ran Poliakine, founder and CEO of Nanox.

“Our latest partnership with Nanox has the potential to take Qure.ai’s AI-powered diagnostics to a large network of radiologists and clinicians who can benefit from our faster and accurate CT scan interpretation. Our solution that seamlessly integrates with radiologists’ workflow can transform patient care by allowing radiologists to focus on the more critical and urgent patient cases,” explained Prashant Warier, CEO and co-founder of Qure.ai.

For more information: www.nanox.vision

Related Content

IV contrast-enhanced 2-mSv 4-mm-thick transverse and coronal (b) CT images show inflamed diverticula (arrows), segmental colonic wall thickening, and adjacent pericolic fat stranding. Image courtesy of the American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

IV contrast-enhanced 2-mSv 4-mm-thick transverse and coronal (b) CT images show inflamed diverticula (arrows), segmental colonic wall thickening, and adjacent pericolic fat stranding. Image courtesy of the American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Computed Tomography (CT) | April 09, 2021
April 9, 2021 — According to an open-acc...
Varian announced it is collaborating with Google Cloud to build an advanced artificial intelligence (AI) based diagnostic platform to aid in the fight against cancer. Varian and Google Cloud AI embarked on a deployment journey, using Neural Architecture Search (NAS) technology via Google Cloud AI Platform, to create AI models for organ segmentation — a crucial and labor-intensive step in radiation oncology that can be a bottleneck in the cancer treatment clinical workflow.
News | Artificial Intelligence | April 08, 2021
April 8, 2021 — Varian announced it is collaborating with Google...
Brain tumors edged out by artificial intelligence: VBrain applies auto-contouring to the three most common types of brain tumors: brain metastasis, meningioma and acoustic neuroma.

Brain tumors edged out by artificial intelligence: VBrain applies auto-contouring to the three most common types of brain tumors: brain metastasis, meningioma and acoustic neuroma.

News | Artificial Intelligence | April 07, 2021
April 7, 2021 — Vysioneer, a leader in a...
Axial chest CT examination in a 54-year-old participant. A, On the axial noncontrast chest CT image, the pectoralis muscle (PM) area was segmented and measured in the section above the aortic arch. B, The subcutaneous adipose tissue (SAT) area as the area between the PM and the skin surface on the same section was also measured and the attenuation of pixels in the SAT area was used to determine the individualized threshold for the intermuscular adipose tissue (IMAT). C, The IMAT within the PM was segmented

Axial chest CT examination in a 54-year-old participant. A, On the axial noncontrast chest CT image, the pectoralis muscle (PM) area was segmented and measured in the section above the aortic arch. B, The subcutaneous adipose tissue (SAT) area as the area between the PM and the skin surface on the same section was also measured and the attenuation of pixels in the SAT area was used to determine the individualized threshold for the intermuscular adipose tissue (IMAT). C, The IMAT within the PM was segmented as the areas with Hounsfield units below this threshold for the IMAT (arrowheads). Image courtesy of the Radiological Society of North America

News | Computed Tomography (CT) | April 07, 2021
April 7, 2021 — Body composition information derived from routine chest...
Ultrasound is an invaluable diagnostic tool for the early detection of breast cancer, but the classification of lesions is sometimes challenging and time consuming. Could artificial intelligence hold the answer to solving these problems? Graphic courtesy of Chinese Medical Journal

Ultrasound is an invaluable diagnostic tool for the early detection of breast cancer, but the classification of lesions is sometimes challenging and time consuming. Could artificial intelligence hold the answer to solving these problems? Graphic courtesy of Chinese Medical Journal

News | Artificial Intelligence | April 06, 2021
April 6, 2021 — In 2020, the International Agency for Research on...
Nano-X Imaging Ltd (Nanox), an innovative medical imaging technology company, announced that its single-source Nanox.ARC digital x-ray technology has received 510(k) clearance from the US Food and Drug Administration.
News | X-Ray | April 02, 2021
April 2, 2021 — Nano-X Imaging Ltd.
Elsevier’s STATdx, a leading radiology diagnostic decision support solution, now includes select Merit-Based Incentive Payment System (MIPS) Measures validated by MDinteractive
News | Clinical Decision Support | April 02, 2021
April 2, 2021 — Elsevier, a global leader in research publishing and information analytics, announced a partnership w